title: Calcification inhibitors in vascular calciphylaxis associated with normal renal function.
authors.forename: Vincent
authors.initials: V
authors.lastname: Brandenburg
authors.forename: Nadia
authors.initials: N
authors.lastname: Al-Fakhri
authors.forename: Katharina
authors.initials: K
authors.lastname: Nemeth
authors.forename: Claudia
authors.initials: C
authors.lastname: Goettsch
authors.forename: Leon J
authors.initials: LJ
authors.lastname: Schurgers
authors.forename: Cees
authors.initials: C
authors.lastname: Vermeer
authors.forename: Lorenz C
authors.initials: LC
authors.lastname: Hofbauer
authors.forename: Michael
authors.initials: M
authors.lastname: Schoppet
mesh_terms: D002114:Calcinosis / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D002115:Calciphylaxis / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D002135:Calcium-Binding Proteins / Q000097:blood / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000097:blood / Q000378:metabolism; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D053244:Osteoprotegerin / Q000097:blood / Q000378:metabolism; D014652:Vascular Diseases / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D055815:Young Adult; D060749:alpha-2-HS-Glycoprotein / Q000378:metabolism; D000097568:Matrix Gla Protein
chemical_list: D002135:Calcium-Binding Proteins; D016326:Extracellular Matrix Proteins; D053244:Osteoprotegerin; D060749:alpha-2-HS-Glycoprotein; D000097568:Matrix Gla Protein; C556354:AHSG protein, human; C506030:TNFRSF11B protein, human